Valuation Cumberland Pharmaceuticals Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-25 EDT			5-day change	1st Jan Change
8.700 ^USD	+10.97%		+14.02%	+118.59%

08-07	Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010.	CI
08-04	Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	44.3	68.9	32.54	26.7	33.28	59.53
Change	-	55.54%	-52.77%	-17.94%	24.62%	78.87%
Enterprise Value (EV) ¹	36.62	57.92	33.75	26.81	35.89	58.26
Change	-	58.17%	-41.74%	-20.55%	33.85%	62.34%
P/E	-13.4x	-19.8x	-5.88x	-4.07x	-5.14x	-20.8x
PBR	0.94x	1.61x	0.89x	0.85x	1.45x	2.39x
PEG	-	-2.73x	-0.1x	-0.3x	-1.08x	0.4x
Capitalization / Revenue	1.18x	1.91x	0.77x	0.68x	0.88x	1.34x
EV / Revenue	0.98x	1.61x	0.8x	0.68x	0.95x	1.31x
EV / EBITDA	-22.4x	-18.9x	-89.6x	-21x	-23.5x	43.1x
EV / EBIT	-5.74x	-7.54x	-5.92x	-4.32x	-5.58x	-20.9x
EV / FCF	-19.5x	160x	14x	2.87x	-45x	9.05x
FCF Yield	-5.12%	0.62%	7.12%	34.8%	-2.22%	11.1%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.2202	-0.2362	-0.3825	-0.44	-0.4609	-0.1909
Distribution rate	-	-	-	-	-	-
Net sales ¹	37.44	35.99	42.01	39.55	37.87	44.52
EBITDA ¹	-1.633	-3.071	-0.3768	-1.275	-1.53	1.353
EBIT ¹	-6.382	-7.677	-5.705	-6.211	-6.432	-2.792
Net income ¹	-3.339	-3.508	-5.57	-6.279	-6.48	-2.836
Net Debt ¹	-7.677	-10.98	1.201	0.1069	2.608	-1.264
Reference price ²	2.950	4.670	2.250	1.792	2.370	3.980
Nbr of stocks (in thousands)	15,017	14,755	14,464	14,905	14,042	14,957
Announcement Date	3/12/21	3/11/22	3/13/23	3/13/24	3/7/25	3/9/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CUMBERLAND PHARMACEUTICALS INC.	-	-	-	-	130M
ELI LILLY AND COMPANY	35.12x	12.73x	25.81x	0.56%	1,100B
JOHNSON & JOHNSON	30.38x	-	-	1.97%	658B
ABBVIE INC.	33.92x	7.84x	16.3x	2.58%	470B
ROCHE HOLDING AG	20.83x	4.94x	12.23x	2.67%	372B
NOVARTIS AG	22.71x	5.84x	14.47x	2.73%	304B
ASTRAZENECA PLC	21.88x	4.48x	12.79x	1.96%	264B
AMGEN INC.	27.97x	7.21x	12.8x	2.28%	239B
NOVO NORDISK A/S	13.99x	4.96x	10.35x	3.67%	213B
GILEAD SCIENCES, INC.	-45.46x	6.56x	25.6x	2.22%	184B
Average	17.93x	6.82x	16.29x	2.29%	380.3B
Weighted average by Cap.	25.31x	8.41x	18.55x	1.89%